# US 2026/0083966 A1 · Reservoir for use with a medical device and system for interventional drug delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083966 A1
- Document ID: US20260083966A1
- Status: Published application
- Kind: A1
- Application number: 19/339,069
- Filed: 2025-09-24
- Published: 2026-03-26
- Earliest claimed: 2024-09-25
- Assignees: Continuity Biosciences, LLC
- Applicants: Continuity Biosciences, LLC
- Inventors: William Daunch; Javier de Ana; Casey Haigh; Brendan Berkel; Elliott Hannah
- Web page: https://patentgrep.com/patent/US20260083966A1

## CPC

- A61K 31/555: containing heavy metals, e.g. hemin, hematin, melarsoprol
- A61N 1/325: {for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428)}
- A61K 9/0009: {involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis}
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 31/7068: having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K 31/7105: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/30: Apparatus for iontophoresis, {i.e. transfer of media in ionic state by an electromotoric force into the body}, or cataphoresis
- A61P 35/00: Antineoplastic agents
- A61M 2205/04: implanted
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A surgically implantable reservoir is provided for implantation into a patient for use in an iontophoresis system. The reservoir and system are used for local drug delivery through a target site of internal or external body tissue. The iontophoresis system includes a source electrode and a counter electrode in electrical communication with the source electrode for forming a localized electric field at the target site. A fluid cargo may comprise a drug solution to be delivered to target tissue. For example, a chemotherapeutic drug solution or any other fluid polar substance may be delivered via the reservoir. In one embodiment, the fluid cargo may include ribonucleic acid molecules.

## Claims

### Claim 1

A surgically implantable reservoir for implantation into a patient for use in an iontophoresis system for local drug delivery through a target site of internal body tissue, the iontophoresis system including a source electrode and a counter electrode in electrical communication with the source electrode for forming a localized electric field at the target site, the reservoir comprising:
a housing having an inner surface defining
a first enclosed chamber having an inlet opening spaced from an outlet opening for flow of fluid including the drug through the first chamber from the inlet opening to the outlet opening, and
a second enclosed chamber having a smaller volume than the first chamber and an inlet opening spaced from an outlet opening for flow of fluid including the drug through the second chamber from the inlet opening to the outlet opening, wherein outlet of the first chamber is in fluid communication with the inlet of the second chamber, and wherein the second chamber is adapted for holding the source electrode,
the housing comprising
a first membrane at least partially defining the first chamber and capable of interacting with the localized electric field, the membrane allowing drug to pass through the membrane and into the targeted tissue when the localized electric field is applied, and
a second membrane separating the first chamber from the second chamber,, the second membrane allowing drug to pass through the membrane and into the first chamber when the localized electric field is applied; and
means for securing the housing to the tissue of the target site,
wherein fluid flow through the second chamber from the inlet opening to the outlet opening moves gas bubbles formed by electrolysis from the surface of the electrode and carries the bubbles through the outlet opening of the second chamber.

### Claim 2 (depends on 1)

The reservoir as recited in claim 1, wherein the outlet opening in the second chamber is opposite the inlet opening of the second chamber.

### Claim 3 (depends on 1)

The reservoir as recited in claim 1, wherein the housing securing means comprises a skirt around at least a portion of the reservoir, wherein the skirt may be sutured to tissue at the target site.

### Claim 4 (depends on 3)

The reservoir as recited in claim 3, wherein the skirt has suture openings.

### Claim 5 (depends on 1)

The reservoir as recited in claim 1, wherein the housing securing means comprises a biological adhesive, microneedles, or staples.

### Claim 6 (depends on 1)

The reservoir as recited in claim 1, wherein the membrane comprises natural or synthetic polyomers, including cellulose acetate, polysulfone, polycarbonate, polyamide, and polyacryl-polyamide acrylate.

### Claim 7

A reservoir for use in an iontophoresis system for local drug delivery through an external target site of body tissue, the iontophoresis system including a source electrode and a counter electrode in electrical communication with the source electrode for forming a localized electric field at the target site, the reservoir comprising:
a housing for accommodating the source electrode, the housing having an inner surface defining an enclosed chamber having an inlet opening spaced from an outlet opening for flow of fluid including the drug through the chamber from the inlet opening to the outlet opening,
a membrane at least partially defining the chamber and capable of interacting with the localized electric field, the membrane allowing drug to pass through the membrane and into the targeted tissue when the localized electric field is applied, an inlet tube in fluid communication with the inlet of the housing;
an outlet tube in fluid communication with the outlet of the housing and extending at an angle of between about 30 degrees and about 90 degrees relative to a plane including the membrane;
and
a handle secured to the housing for manual placement of the membrane against the tissue of the target site,
wherein fluid flow through the chamber from the inlet opening to the outlet opening moves gas bubbles formed by electrolysis from the surface of the electrode and carries the bubbles through the outlet opening.

### Claim 8 (depends on 1)

The reservoir as recited in claim 1, wherein the outlet opening is opposite the inlet opening.

### Claim 9 (depends on 1)

The reservoir as recited in claim 1, wherein the membrane comprises natural or synthetic polyomers, including cellulose acetate, polysulfone, polycarbonate, polyamide, and polyacryl-polyamide acrylate.

### Claim 10

An iontophoresis system for local drug delivery through a target site of internal body tissue, the iontophoresis system comprising:
a source electrode;
a counter electrode in electrical communication with the source electrode, the counter electrode being configured to cooperate with the source electrode to form a localized electric field at the target site;
a fluid cargo including the drug, the fluid cargo capable of being delivered through the tissue of the target site when exposed to the localized electric field formed between the source electrode and the counter electrode;
a surgically implantable reservoir adapted to be secured to the target site, the reservoir comprising
a housing having an inner surface defining an enclosed chamber and an inlet opening and an outlet opening for cargo flow through the chamber, the housing capable of interacting with the localized electric field to release the cargo,
a fluid channel from the outlet opening to the exterior of the housing, and
a platform extending inwardly into the chamber from the inner surface of the housing such that the platform and an adjacent portion of the inner surface of the housing define a trough surrounding the platform, the platform configured for holding the source electrode; and
means for securing the housing to the tissue of the target site,
wherein cargo flow through the reservoir from the inlet opening to the outlet opening moves gas bubbles formed by electrolysis from the surface of the electrode and carries the bubbles through the outlet opening and not the channel exterior of the housing.

### Claim 11 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the source electrode comprises platinum.

### Claim 12 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the cargo comprises anesthetics, vaccines, chemotherapeutic agents, metabotites, immunomodutators, antioxidants, antibiotics, and ion channel regulators, or hormones.

### Claim 13 (depends on 12)

The iontophoresis system as recited in claim 12, wherein the cargo further comprises one or more pharmaceutically acceptable carriers, excipients, or diluents.

### Claim 14 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the cargo comprises a therapeutic agent.

### Claim 15 (depends on 14)

The iontophoresis system as recited in claim 14, wherein the therapeutic agent comprises gemcitabine.

### Claim 16 (depends on 10)

The iontophoresis system as recited in claim 10, further comprising a source of cargo in fluid communication with the inlet opening for a flow of cargo into the housing.

### Claim 17 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the outlet opening is spaced from the inlet opening.

### Claim 18 (depends on 17)

The iontophoresis system as recited in claim 17, wherein the outlet opening is opposite the inlet opening.

### Claim 19 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the housing securing means comprises a skirt around at least a portion of the reservoir, wherein the skirt may be sutured to tissue at the target site.

### Claim 20 (depends on 19)

The iontophoresis system as recited in claim 19, wherein the skirt comprises a plurality of anchor points defining suture openings.

### Claim 20 (depends on 10)

The iontophoresis system as recited in claim 10, wherein the housing securing means comprises a biological adhesive.

### Claim 22 (depends on 10)

The iontophoresis system as recited in claim 10, wherein at least a portion of the housing comprises a membrane, the membrane allowing drug to pass through the membrane and into the targeted tissue when a localized electric field is applied.

### Claim 23 (depends on 22)

The iontophoresis system as recited in claim 22, wherein the membrane comprises natural or synthetic polyomers, including cellulose acetate, polysulfone, polycarbonate, polyamide, or polyacryl-polyamide acrylate.

### Claim 24

A surgically implantable reservoir for implantation into a patient for use in an ontophoresis system for local delivery of ribonucleic acid molecules through a target site of internal body tissue, the iontophoresis system including a source electrode and a counter electrode in electrical communication with the source electrode for forming a localized electric field at the target site, the reservoir comprising:
a housing having an inner surface defining an interior cavity open one side for accommodating the electrode;
a membrane spanning the open side of the housing for covering the cavity in the housing forming an enclosed chamber, the membrane capable of interacting with the localized electric field for allowing RNA molecules to pass through the membrane and into the targeted tissue when the localized electric field is applied;
an absorbent pad for holding the ribonucleic acid molecules and disposed within the chamber;
a buffer gel partially filling the chamber;
a spring assembly for biasing the electrode into the buffer gel and toward the pad and the membrane; and
means for securing the housing to the tissue of the target site.

### Claim 25 (depends on 24)

The iontophoresis system as recited in claim 24, wherein the housing securing means comprises a skirt around at least a portion of the reservoir, wherein the skirt may be sutured to tissue at the target site.

### Claim 26 (depends on 24)

The iontophoresis system as recited in claim 24, wherein the skirt comprises a plurality of anchor points defining suture openings.

### Claim 27 (depends on 24)

The iontophoresis system as recited in claim 24, wherein the housing securing means comprises a biological adhesive.

### Claim 28 (depends on 24)

The iontophoresis system as recited in claim 24, wherein the membrane comprises natural or synthetic polymers, including cellulose acetate, polysulfone, polycarbonate, polyamide, or polyacryl-polyamide acrylate.
